Pharmaceuticals, Biotechnology and Life Sciences
Silence Therapeutics and Alnylam Pharmaceuticals have settled for royalty on net sales of Onpattro in EU, the companies said in separate press releases Monday, noting they will dismiss court proceedings
Silence Therapeutics strengthen the protection for its innovative chemical modification technology in Europe, as the European Patent Office granted it…
Silence Therapeutics got the US Patent and Trade Mark Office on Tuesday, after previously reporting issuance of a notice of allowance…
Silence Therapeutics has made a new appointment to its board of directors, in a significant moment in the transition of…
Silence Therapeutics and Quark Pharmaceuticals have settled in the arbitration regarding a milestone payment, as Silence is to receive a…
Silence Therapeutics plc, a London-headquartered drug development company, dealing with the delivery of novel RNA interference (RNAi) therapeutics for the treatment…